Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BIRC2 | Q13490 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.31 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 2/20 | 0.31 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.31 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.31 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.31 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.31 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6100284 | 0.81 | BIRC2 (0.41) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| SCHEMBL8815561 | 0.78 | BIRC2 (0.40) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| SCHEMBL14097349 | 0.78 | BIRC2 (0.41) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| Tert-Butyl Formate SCHEMBL28025928 | 0.76 | BIRC2 (0.35) | BIRC2 | |
| SCHEMBL9187015 | 0.75 | BIRC2 (0.40) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| SCHEMBL15894887 | 0.72 | BIRC2 (0.38) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| SCHEMBL2628598 | 0.72 | BCHE (0.38) | — | |
| SCHEMBL28026498 | 0.71 | MAPT (0.45) | BIRC2MAPTALOX15HSD17B10GRIN2D | |
| SCHEMBL2628597 | 0.71 | HSD17B10 (0.41) | HSD17B10 | |
| Tert-Butyl Formate SCHEMBL27947062 | 0.70 | BIRC2 (0.49) | BIRC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8580297-B2 | Components for producing amphoteric liposomes | MARINA BIOTECH, INC. (US) | 2013-11-12 | — | — | US | disclosed |
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | MARINA BIOTECH, INC. | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120100205-A1 | COMPONENTS FOR PRODUCING AMPHOTERIC LIPOSOMES | PHOSPHO1, SGMS1, CHMP4B | BIRC2 357/4885LTA4H 175/4885MAPT 3179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.